The major objective of this study was to identify and analyze signal transduction factors that function with the CR4 receptor kinase. We decided to pursue this analysis in Arabidopsis but the Arabidopsis CR4 (ACR4) mutant phenotype was unexpectedly subtle compared to maize, suggesting that redundant functions might exist in Arabidopsis. An analysis of other members of the ACR4 related receptor (CRR) family produced biochemical evidence consistent with some of them functioning in ACR4 signal transduction but genetic analysis indicated their functions were not necessary [Cao, 2005 #51].
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To identify downstream signal transduction components we searched for proteins that interacted with the CR4 cytoplasmic domain. We screened a seedling cDNA library by yeast 2-hybrid interaction and obtained 94 clones. Interactions were quantified by ONPG assay and the 14 strongest interactors were selected for further analysis. These represented isolates of 6 different cDNAs:
The two remaining clones contained the coding region for the cytoplasmic domain of two different LRR receptor like kinases. This opens the possibility that these might function as heterodimers with CR4.
The interactions for all 6 proteins were verified by in vitro pull down assays. Each of the interactors was subcloned into a bacterial expression vector and expressed in E. coli. The purified proteins containing a c-terminal myc tag were incubated with purified CR4 cytoplasmic domain contaning an n-terminal 6XHIS tag. The 6XHIS proteins were bound to nickel resin beads, eluted and immunoblotted with myc antibodies to detect proteins that co-purified with CR4. All of the interacting proteins except AJH1 were pulled down with CR4 ( Figure 1 ). Each interacting protein was also incubated with a mutant, kinaseinactive form of CR4 in which an essential lysine residue in subdomain 2 was replaced by alanine (CR4KA). All the proteins but AJH1 also interacted with this protein indicating that CR4 kinase activity was not required for any of the interactions.
The ability of CR4 to phosphorylate the interacting proteins was tested in vitro. Two molecular weight forms of CR4 purify when expressed in bacteria. The two bands migrate similarly to the interacting proteins in SDS PAGE, and the strong autophosphorylation of CR4 masked potential phosphorylation of the interactors. Therefore, CR4 was covalently bound to NHS activated sepharose and then incubated with the interacting proteins in kinase buffer containing γ[32P]ATP. The beads were centrifuged and the pellet and supernatants collected. The pellet was boiled in loading buffer, then centrifuged again to disrupt interactions with CR4. Both the supernatant and pellet fractions were electrophoresed and autoradiographed. The kinase inactive mutant CR4 is known to act as a substrate for active CR4 and was used for a positive control. As shown in figure 2, the interacting proteins were all phosphorylated by CR4 except the lipase and PP2B regulatory subunit, which were only weakly phosphorylated.
One possible scenario for CR4 signaling is that phosphorylation could promote dissociation of the interactors from CR4. If this were the case, the majority of the phosphorylated proteins would be expected to be found in the supernatant fraction. However, most of the phosphorylated proteins were bound to the CR4 beads indicating that they probably remain bound to CR4 following phosphorylation.
The CR4 kinase domain consists of a short, approximately 40 residue juxtamembrane region, the kinase catalytic domain, and a 120 residue carboxy terminal domain. To narrow down the regions of CR4 that the various interactors bind to, the carboxy terminus was deleted and interactions were tested by pull-down assays. The carboxy domain was not necessary for the interactions of AJH2, or either RLK, but was required for the interactions of the lipase and PP2B. This suggests that these latter two proteins may interact with the carboxy terminus. This was verified in a yeast 2-hybrid assay. These results have been submitted for publication.
We also identified candidate interactors with the extracellular receptor domain. The extracellular domain contains a region of similarity to the ligand binding domain of mammalian tumor necrosis factor receptor (TNFR). We hypothesize this may be the ligand binding domain for ACR4. In one approach, yeast 2-hybrid was again used and five candidate proteins identified that interact with the ACR4 TNFR-like domain. One, CAXIP4, can be verified with in vitro pull-down experiments. A genetic knock-out produces no mutant phenotype indicating this protein is not necessary for ACR4 signaling. We are continuing with biochemical approaches to test whether these proteins interact in vivo, and whether this interaction alters ACR4 activity.
Nine additional candidates were identified in a collaborative bioinformatic approach where a genome wide scan of Arabidopsis predicted amino acid sequences of were threaded onto the TNF structure. Three with high scores and other attributes such as signal peptides, that would be consistent with a secreted protein, are being analyzed further by genetic and biochemical means. We expect to complete the analysis of the extracellular interactors within the year.
